Arimidex and Activated partial thromboplastin time prolonged - a phase IV clinical study of FDA data

Summary:

Activated partial thromboplastin time prolonged is reported as a side effect among people who take Arimidex (anastrozole), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Lasix, and have Axillary mass.

The phase IV clinical study analyzes which people have Activated partial thromboplastin time prolonged when taking Arimidex. It is created by eHealthMe based on reports of 21,680 people who have side effects when taking Arimidex from the FDA, and is updated regularly.

What is Arimidex?

Arimidex has active ingredients of anastrozole. It is often used in breast cancer. eHealthMe is studying from 22,642 Arimidex users. Check the latest studies of Arimidex.

What is Activated partial thromboplastin time prolonged?

Activated partial thromboplastin time prolonged is found to be associated with 761 drugs and 1,208 conditions by eHealthMe. Check the latest studies of Activated partial thromboplastin time prolonged.

On Jul, 11, 2026

21,680 people reported to have side effects when taking Arimidex.
Among them, 12 people (0.06%) have Activated partial thromboplastin time prolonged.

Could Arimidex cause Activated partial thromboplastin time prolonged?

Among these 12 people:

How long have people been on Arimidex when they have Activated partial thromboplastin time prolonged? *

What is the gender of people who have Activated partial thromboplastin time prolonged when taking Arimidex? *

female: 100 %
male: 0.0 %

What is the age of people who have Activated partial thromboplastin time prolonged when taking Arimidex? *

What are other drugs people take besides Arimidex? *

What are other side effects people have besides Activated partial thromboplastin time prolonged? *

Thrombocytopenia (decrease of platelets in blood): 4 people, 33.33%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4 people, 33.33%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 3 people, 25.00%
Haematuria (presence of blood in urine): 3 people, 25.00%
Protein Total Decreased: 3 people, 25.00%
Hypertransaminasaemia: 3 people, 25.00%
Weakness: 3 people, 25.00%
Blood Creatinine Increased: 3 people, 25.00%
Blood Phosphorus Decreased: 3 people, 25.00%
Blood Potassium Decreased: 3 people, 25.00%

What are the existing conditions these people have? *

Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 3 people, 25.00%
Axillary Mass: 3 people, 25.00%
Osteoporosis (bones weak and more likely to break): 2 people, 16.67%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 16.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 16.67%
Metastases To Bone (cancer spreads to bone): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
Constipation: 1 person, 8.33%
Breast Cancer Metastatic: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Arimidex and have Activated partial thromboplastin time prolonged?

- Check whether Activated partial thromboplastin time prolonged is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Arimidex:

Arimidex (22,642 reports)

Activated partial thromboplastin time prolonged treatments and more:

Activated partial thromboplastin time prolonged (8,799 reports)

How severe was Activated partial thromboplastin time prolonged and when was it recovered:

Activated partial thromboplastin time prolonged in Arimidex

Expand to all the drugs that have ingredients of anastrozole:

Activated partial thromboplastin time prolonged and drugs with ingredients of anastrozole (12 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Arimidex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Activated partial thromboplastin time prolonged:

Activated partial thromboplastin time prolonged (761 drugs)

Browse all the conditions that are associated with Activated partial thromboplastin time prolonged:

Activated partial thromboplastin time prolonged (1,208 conditions)

Related publications that referenced our studies

Manjunatha N, Ganjekar S, Mahendra JV, Kilara N, Srinivasa R, "Tardive Dyskinesia Associated With Anastrozole", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .
Manjunatha N, Ganjekar S, Mahendra JV, Kilara N, Srinivasa R, "Tardive Dyskinesia Associated With Anastrozole", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on anastrozole (the active ingredients of Arimidex) and Arimidex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.